Niche market Small veterinary medical device company focused on regenerative medicine for companion animals, presenting a specialized audience of veterinary clinics and hospitals that may value point-of-care autologous therapies.

Onsite processing Devices enable on-site processing of blood or bone marrow aspirate within 30 minutes, offering convenience, cost savings, and peace-of-mind for pet owners—a strong selling point for clinics aiming to reduce lab dependence.

Product portfolio Portfolio includes Pro-Stride APS, Restigen PRP, and CenTrate BMA Concentrate, suggesting upsell opportunities across regenerative medicine workflows and potential bundling with related devices or consumables.

Revenue potential Current revenue under $1M with a very small team (2-10 employees) indicates a lean operation open to partnerships, distributors, or white-label arrangements to accelerate market reach.

Growth signals Nearly 20 years in development and a focus on companion animal orthopedics align with rising demand for non-surgical joint preservation therapies, offering a foothold to engage clinics expanding regenerative medicine offerings.